Treating Hepatitis C & Opioid Use Disorder

Date: October 13, 2020 12-1PM

Featured Speaker(s): Richard Rawson, PhD, and Veronica Velasquez-Morfin, MD

Description: People who use drugs have a high prevalence of hepatitis C virus (HCV) and other infectious diseases along with significant morbidity associated with drug use, especially when injection drug use is involved. This webinar will address the connections between infectious diseases, opioid use disorder (OUD), and other drug use-related harms, as well as effective treatments for HCV and OUD.

For more information, contact Cfrable@mednet.ucla.edu

Continuing the Conversation: Addressing Stimulant Use in Primary Care

Featured Speaker(s): Richard Rawson, PhD, and Veronica Velasquez-Morfin, MD

Description: This is a follow up session to the September 8th presentation in which Richard Rawson, PhD, discussed the current epidemiology of stimulant use in patients with and without opioid use disorder, as well as clinical challenges and current evidence based treatment practices. Veronic Velasquez-Morfin, MD, presented cases for discussion to highlight clinical guidelines in a variety of health care settings. Additional cases and clinical questions will be discussed.

For more information, contact Cfrable@mednet.ucla.edu

Addressing Stimulant Use in Primary Care

Featured Speaker(s): Richard Rawson, PhD, and Veronica Velasquez-Morfin, MD

Description: Addressing Stimulant Use in Primary Care. Use of methamphetamine and cocaine by patients taking medications for addiction treatment (MAT) continues to rise and has become a common challenge for providers in primary care settings. Richard Rawson, PhD will discuss current epidemiology of stimulant use in patients with and without opioid use disorder, common clinical challenges, and current evidence-based treatment practices. Veronica Velasquez-Morfin will discuss clinical approaches in a variety of health care settings, including primary care, emergency departments, and MAT programs.

For more information, contact Cfrable@mednet.ucla.edu

   

* These documents are not yet 508 compliant

Treatment of Justice Involved Clients with Substance Use Disorders

Featured Speaker: Igor Koutsenok, MD

Description: In this hour-long webinar, Igor Koutsenok, MD, will provide an overview of treatment interventions for justice involved clients with substance use disorders. This presentation will cover recent data on opioid use in criminal justice populations as well as risk factors for criminality and factors to consider when providing treatment.

For more information, contact Cfrable@mednet.ucla.edu

   

Indigenous Health and the Opioid Epidemic

Featured Speaker: Kawika Liu, MD, PhD, JD, FAAP, FASAM

Description: In this one-hour session, Kawika Liu, MD, PhD, JD, FAAP, FASAM, will provide an overview of the opioid epidemic and indigenous health. The presentation will include discussion of the impact of trauma, genetic risk and resilience, molecular epidemiology, and substance use on the overall health of indigenous people.

For more information, contact Cfrable@mednet.ucla.edu

   

* These documents are not yet 508 compliant

Treating Patients with Pain and Opioid Use Disorder (OUD)

Featured Speaker: Angella Barr, MD

Description: For over a decade, treating patients with pain routinely involved the extensive use of opioids. However, the opioid crisis in the US has led to new practices and regulations related to prescribing opioids. As a result, many providers are facing challenges treating patients who may need opioids for pain relief and also have or are at high risk for developing an opioid use disorder (OUD). This one-hour training will focus on the current understanding of the nexus of pain and OUD, with a focus on best practices to address the needs of patients with pain and OUD in primary care settings.

For more information, contact Cfrable@mednet.ucla.edu

   

Substance Use Navigators: Changing Roles in the Pandemic

Featured Speaker: Arianna Sampson, PA-C

Description: This one hour webinar is a collaborative effort by three leading initiatives in California working to increase access to MAT for patients with opioid use disorder. As COVID-19 continues to spread, access to treatment for other conditions continues to change. For people with opioid use disorder who seek or need to continue medications for addiction treatment (MAT), access to care at the Emergency Department (ED) is also changing. This webinar will provide an overview of ways access to care, including care in the ED, interactions with substance use navigators (SUNs), and referrals to treatment, including to Narcotic Treatment Programs (NTPs) that provide all forms of MAT, are being adapted to help patients get the services they need in a changing health care environment.

   

Treating Pregnant Women with Opioid Use Disorder (OUD)

Featured Speaker: Angella Barr, MD

Description: This one-hour webinar is designed to assist health care providers caring for pregnant and postpartum women understand evidence-based practices to treat this vulnerable population. Angella Barr, MD, will cover the science and best practices in treating pregnant women with OUD and their infants, as well as a case review and discussion.

   

Co-occurring Substance Use and MOUD

Featured Speaker: Veronica Velasquez-Morfin, MD

Description: This one-hour web training will provide an overview of best practices to treat patients with opioid use disorder who are also using other substances, such as stimulants, cannabis, sedatives, and other opioids. Research and practical strategies will be discussed.

 

Shared Medical Appointments for MAT Treatment

Featured Speaker: Cheryl Ho, MD

Description: This one-hour web training will provide an overview of using shared medical appointments in MAT treatment. Dr. Ho will describe the research behind this approach, the benefits, and practical steps to implement group visits in treatment settings.

   

Starting Treatment: Buprenorphine Induction 101

Featured Speaker: Candy Stockton, MD

Description: This one-hour web training will provide an overview of best practices on how to start buprenorphine treatment for opioid use disorder in a variety of settings, including hospitals, emergency department, and office-based settings. The presenter will also cover safe home induction protocols and other recommendations.

   

Demystifying DEA's Role in MAT Regulation & Implementing a Zero Risk Program

Featured Speaker: Dennis A. Wichern

Description: This one-hour web training will provide an overview of the authority of the Drug Enforcement Administration (DEA), Food and Drug Administration (FDA), and Substance Abuse and Mental Health Services Administration (SAMHSA) as it relates to regulating the use of medications in the provision of treatment for opioid use disorders (OUD), along with a review of national studies, risk mitigation strategies, case studies, emerging issues, commonly asked questions, and strategies for preventing a DEA audit. The goal of the training session is to alleviate provider concerns relative to operating a MAT medical practice.

   

Opioids as an Emergency

Featured Speaker: Aimee Moulin, MD

Description: In this one-hour webinar, Aimee Moulin, MD, frames opioid use disorder (OUD) as a medical emergency and highlights the role emergency departments and other health care providers can play in helping patients start treatment for OUD.